Andrew Arno, Director at Oncocyte Corp (OCX), bought 275,523 shares at $0.97 ($256K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $0.93 | 34,477 | $32K | 12.5% |
| 3 | $0.97 | 115,523 | $112K | 43.7% |
| 4 | $0.97 | 115,523 | $112K | 43.7% |
| Total | $0.93 avg | 275,523 | $256K | 100% |
| Filing → |
| XXII | BUY | 2024-01-08 | $17K | — | Filing → |
| OCX | BUY | 2022-12-28 | $88K | — | Filing → |
| SMSI | BUY | 2022-08-22 | $64K | — | Filing → |